The Supreme Court of the United States rejected on Tuesday June 21 the appeal of Monsanto, now owned by the German group Bayer. A decision which makes final for the company its condemnation to pay 25 million dollars (about 23.5 million euros) to a pensioner who attributes his cancer to the weedkiller Roundup.
The Supreme Court ruling upholds Monsanto’s appeal conviction in the lawsuit brought by Edwin Hardeman, who was diagnosed with non-Hodgkin’s lymphoma in 2015. Edwin Hardeman was one of the first plaintiffs to sue the company, blaming his cancer on the herbicide he had used on his large property for twenty-five years.
Bayer defends Roundup
In accordance with custom, the high court did not justify its decision, which risks having serious consequences for the group, targeted by more than 30,000 comparable complaints. The Bayer group said it had set aside an additional 4.5 billion dollars (more than 4 billion euros) to deal with new procedures. Bayer shares fell 4.07% to €60.79 on the Frankfurt Stock Exchange after the announcement.
“Bayer respectfully disagrees with the Supreme Court’s decision,” reacted the group in a press release, explaining to be “fully prepared to deal with the legal risk associated with potential future claims in the United States.” However, he clarified “Admit no wrong or responsibility” and “continue to support its Roundup products, a valuable tool for efficient agricultural production around the world”.